• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.了解系统性红斑狼疮患者的预期结果及其对使用皮质类固醇的风险和益处的看法。
Lupus. 2018 Mar;27(3):475-483. doi: 10.1177/0961203317726375. Epub 2017 Aug 31.
2
Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark.阿尼鲁单抗治疗可改善系统性红斑狼疮患者的生活质量,并降低疾病活动度和皮质类固醇的使用:丹麦的一项定性研究。
Lupus. 2024 Aug;33(9):962-973. doi: 10.1177/09612033241261746. Epub 2024 Jun 20.
3
Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice Experiment.患者对系统性红斑狼疮治疗方法的偏好——一项离散选择实验。
Patient. 2024 May;17(3):287-300. doi: 10.1007/s40271-023-00670-7. Epub 2024 Jan 25.
4
Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids.系统性红斑狼疮患者体重减轻和疲劳改善:低升糖指数饮食与热量限制饮食对照试验,比较两种饮食方案在接受皮质类固醇治疗患者中的作用。
Lupus. 2012 May;21(6):649-55. doi: 10.1177/0961203312436854. Epub 2012 Feb 6.
5
Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.系统性红斑狼疮患者使用皮质类固醇的负担:德尔菲小组的结果
Lupus. 2014 Sep;23(10):1006-13. doi: 10.1177/0961203314532699. Epub 2014 Apr 30.
6
Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.系统性红斑狼疮发作的患者和医生观点:一项定性研究。
J Rheumatol. 2024 May 1;51(5):488-494. doi: 10.3899/jrheum.2023-0721.
7
Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.新诊断系统性红斑狼疮患者的纵向治疗模式及相关结局
Clin Ther. 2016 Mar;38(3):610-24. doi: 10.1016/j.clinthera.2016.01.016. Epub 2016 Feb 19.
8
Corticosteroid-associated lupus pancreatitis: a case series and systematic review of the literature.皮质类固醇相关性狼疮胰腺炎:病例系列及文献系统回顾。
Lupus. 2019 May;28(6):731-739. doi: 10.1177/0961203319844004. Epub 2019 Apr 25.
9
Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus.系统性红斑狼疮患者的皮质类固醇与神经心理功能
Arthritis Rheum. 1994 Sep;37(9):1311-20. doi: 10.1002/art.1780370907.
10
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.无论基线时的血清学状态如何,低疾病活动度均与接受贝利尤单抗治疗的系统性红斑狼疮患者的皮质类固醇剂量减少和 flares 次数减少相关:一项真实世界观察性研究。
Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi: 10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23.

引用本文的文献

1
Effectiveness and safety of telitacicept in patients with systemic lupus erythematosus: a single center, retrospective, real-world study.泰它西普治疗系统性红斑狼疮患者的有效性和安全性:一项单中心、回顾性、真实世界研究。
Clin Rheumatol. 2025 Mar;44(3):1113-1122. doi: 10.1007/s10067-025-07348-5. Epub 2025 Feb 4.
2
The Burden of Glucocorticoids: Patterns of Use, Adverse Health Conditions, and Health Care Use in Two Cohorts With Systemic Lupus Erythematosus.糖皮质激素的负担:两个系统性红斑狼疮队列中的使用模式、不良健康状况及医疗保健利用情况
ACR Open Rheumatol. 2024 Dec;6(12):918-926. doi: 10.1002/acr2.11733. Epub 2024 Oct 9.
3
Lifestyle Interventions and Weight Management in Systemic Lupus Erythematosus Patients: A Systematic Literature Review and Metanalysis.系统性红斑狼疮患者的生活方式干预与体重管理:一项系统文献综述和荟萃分析
J Lifestyle Med. 2022 Jan 31;12(1):37-46. doi: 10.15280/jlm.2022.12.1.37.
4
Patient Experiences of Systemic Lupus Erythematosus: Findings From a Systematic Review, Meta-Summary, and Meta-Synthesis.系统性红斑狼疮患者体验的系统性综述、元总结和元综合研究结果。
Arthritis Care Res (Hoboken). 2022 Nov;74(11):1813-1821. doi: 10.1002/acr.24639. Epub 2022 Jul 13.
5
Self-reported disease severity in women with systemic lupus erythematosus.系统性红斑狼疮女性患者的自报疾病严重程度。
Rheumatol Int. 2019 Mar;39(3):533-539. doi: 10.1007/s00296-018-4203-1. Epub 2018 Nov 10.

本文引用的文献

1
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort.糖皮质激素剂量对系统性红斑狼疮患者器官损害风险的影响——霍普金斯狼疮队列研究。
Lupus Sci Med. 2015 Mar 11;2(1):e000066. doi: 10.1136/lupus-2014-000066. eCollection 2015.
2
Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.系统性红斑狼疮患者使用皮质类固醇的负担:德尔菲小组的结果
Lupus. 2014 Sep;23(10):1006-13. doi: 10.1177/0961203314532699. Epub 2014 Apr 30.
3
Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus.红斑狼疮患者临床试验中健康状况受损及疼痛和疲劳对功能的影响。
J Rheumatol. 2013 Nov;40(11):1865-74. doi: 10.3899/jrheum.130046. Epub 2013 Oct 1.
4
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey.系统性红斑狼疮对患者生产力和职业发展的巨大负担:一项欧洲患者驱动的在线调查。
Rheumatology (Oxford). 2013 Dec;52(12):2292-301. doi: 10.1093/rheumatology/ket300. Epub 2013 Sep 18.
5
Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.系统性红斑狼疮患者不良心血管事件的发生率及危险因素。
Am J Epidemiol. 2012 Oct 15;176(8):708-19. doi: 10.1093/aje/kws130. Epub 2012 Sep 27.
6
Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL).成人系统性红斑狼疮患者健康相关生活质量的测量:狼疮生活质量量表(LupusQoL)、系统性红斑狼疮特异性生活质量问卷(SLEQOL)和系统性红斑狼疮生活质量问卷(L-QoL)。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S413-9. doi: 10.1002/acr.20636.
7
Domains of health-related quality of life important and relevant to multiethnic English-speaking Asian systemic lupus erythematosus patients: a focus group study.与多族裔讲英语的亚洲系统性红斑狼疮患者相关且重要的健康相关生活质量领域:一项焦点小组研究。
Arthritis Care Res (Hoboken). 2011 Jun;63(6):899-908. doi: 10.1002/acr.20462.
8
Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study.患者对系统性红斑狼疮与健康相关生活质量概念的看法:一项定性研究。
Lupus. 2010 Dec;19(14):1640-7. doi: 10.1177/0961203310378668. Epub 2010 Aug 13.
9
Quality-of-life measurements versus disease activity in systemic lupus erythematosus.系统性红斑狼疮的生活质量测量与疾病活动度比较。
Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1.
10
PRO development: rigorous qualitative research as the crucial foundation.专业发展:严谨的定性研究是关键基础。
Qual Life Res. 2010 Oct;19(8):1087-96. doi: 10.1007/s11136-010-9677-6. Epub 2010 May 30.

了解系统性红斑狼疮患者的预期结果及其对使用皮质类固醇的风险和益处的看法。

Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

机构信息

1 Department of Pharmaceutical Health Services Research, 12265 University of Maryland School of Pharmacy, Baltimore, MD, USA.

2 Department of Epidemiology and Public Health, 12265 University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Lupus. 2018 Mar;27(3):475-483. doi: 10.1177/0961203317726375. Epub 2017 Aug 31.

DOI:10.1177/0961203317726375
PMID:28857718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5581720/
Abstract

Introduction The use of corticosteroids in systemic lupus erythematosus (SLE) patients requires difficult trade-offs between efficacy and risk of toxicity. This qualitative study examined SLE patients' most desired outcomes and their concerns with corticosteroid use in SLE treatment. Methods SLE patients with current/past experience with using corticosteroids were recruited from the clinics at the Johns Hopkins Lupus Center and the University of Maryland Medical Center. Five in-depth interviews ( N = 5) and four focus groups ( N = 15) were conducted during which discussions were transcribed and analyzed based on a grounded theory approach. Results We identified five major themes describing SLE patients' most desired outcomes: reduction in flares, maintenance of normal activities, minimization of treatment side effects, prevention of future organ damage, and finding a cure. Further, SLE patients reported these primary concerns with the adverse effects of corticosteroids: weight gain, organ damage (particularly bone-related damage), mood swings/irritability, sleep disturbances, and dental issues. Patients appeared to be more concerned with adverse effects that immediately affected their day-to-day lives. Conclusion Knowledge gained during this study better informs how patients view the benefits and risks of corticosteroids. This can facilitate discussions between physicians and patients as they work together to determine the appropriate use of corticosteroids.

摘要

介绍 系统性红斑狼疮 (SLE) 患者使用皮质类固醇需要在疗效和毒性风险之间进行艰难的权衡。这项定性研究探讨了 SLE 患者最希望达到的治疗结果以及他们对 SLE 治疗中皮质类固醇使用的担忧。 方法 从约翰霍普金斯狼疮中心和马里兰大学医学中心的诊所招募了目前/过去有皮质类固醇使用经验的 SLE 患者。共进行了 5 次深入访谈( N = 5)和 4 次焦点小组( N = 15),根据扎根理论方法对讨论进行转录和分析。 结果 我们确定了五个主要主题,描述了 SLE 患者最希望达到的治疗结果:减少发作、维持正常活动、最小化治疗副作用、预防未来器官损伤和寻找治愈方法。此外,SLE 患者报告了这些对皮质类固醇不良反应的主要担忧:体重增加、器官损伤(特别是与骨骼相关的损伤)、情绪波动/易怒、睡眠障碍和牙齿问题。患者似乎更担心那些立即影响日常生活的不良反应。 结论 本研究获得的知识更好地说明了患者如何看待皮质类固醇的益处和风险。这可以促进医生和患者之间的讨论,因为他们共同努力确定皮质类固醇的适当使用。